Average cost per year*
Average cost per beneficiary*
Apraclonidine is used along with other medications to treat serious high pressure inside the eye (glaucoma) for a short time (e.g., 1 month) to help delay or prevent the need for eye surgery. Decreasing high pressure inside the eye may help to prevent decreased vision or blindness. Apraclonidine is thought to work by decreasing the amount of fluid within the eye. NOTE: This is a summary and does NOT have all possible information about this product. This information does not assure that this product is safe, effective, or appropriate for you. This information is not individual medical advice and does not substitute for the advice of your health care professional. Always ask your health care professional for complete information about this product and your specific health needs.
*Origin of the terms and chart data used within this page: https://data.cms.gov/
Yes, Apraclonidine HCl is covered by Medicare.
In 2021, the average cost per dose of Apraclonidine HCl was $11.81.
The average dose of Apraclonidine HCl received per year is 37,414 units
1,692 Medicare beneficiaries received Apraclonidine HCl in 2021, which was a 0.11% from 2020
There were 4,060 claims made by Medicare beneficiaries, which is a -0.04% from 2020
The average spending amount per claim in 2021 was $96.00
The average Medicare spending per beneficiary amount for Apraclonidine HCl was $230.35
The most expensive manufacturer of Apraclonidine HCl is Akorn Inc.
Sandoz is the least expensive manufacturer with an Average Spending Per Dosage Unit of $11.17
Akorn Inc. received $211,492.47
The total amount spent on Apraclonidine HCl by Medicare is $389,748.73
Short Term Medical Insurance
Limited Fixed Indemnity Plans